Intellectual Property

Canada and the life sciences – thoughts on the future

Posted by:

This week, Pugatch Consilium’s Founder and MD, Professor Meir Pugatch, will be addressing a series of gatherings in Montreal and Ottawa to discuss the issue of competitiveness in the Canadian life sciences and, in particular, looking at the role of intellectual property protection in facilitating innovation. At the events, co-hosted by Montreal InVivo and Life Sciences Ontario, Professor Pugatch will outline his thoughts in front of an audience of distinguished guests including Canada’s minister of higher education, sciences and technology.

Drug ...

Continue Reading →
0

Pugatch Consilium Launches New Paper on Clinical Trials

Posted by:

Pugatch Consilium launches new paper on Clinical trials and data transparency examining the public interest case for more pro-active release of clinical trials data and asking whether the benefits to public welfare are outweighed by the hurdles of bureaucracy, patient privacy and concerns over protection of IPRs and commercial confidentiality. Download a copy from the Research & Analysis Reports page.

Continue Reading →
0

The Cronut Recipe, Half Croissant + Half Doughnut = Full Trademark Protection?

Posted by:

Pugatch Consilium’s Jacques Johann Stemmet dives into the pudgy minefield of intellectual property rights and baked goods.

 

The Cronut: Carefully laminated croissant-like dough, delicately fried in grapeseed oil at the perfect temperature, then rolled in sugar, crammed with cream and topped with a glossy glaze. Of course Dominique Ansel has not shared all his tricks to the recipe, but he has informed us of his secret ingredient, trademark protection. This does not mean Ansel can now relax and watch the dough ...

Continue Reading →
0

Monsanto and Myriad: deeper implications

Posted by:

When legal battles reach the Supreme Court, a fair amount of media scrutiny follows as the rulings often delve deeper into the inner meanings of the judges’ interpretations. The high-profile cases of Monsanto vs. Bowman and Myriad Genetics certainly did not go against this formula as they both brought to the forefront the issues of scope and threshold of patent protection respectively. In Monsanto, the Court upheld the principle in which the patent owner may set boundaries and limitations on ...

Continue Reading →
0

Are software patents ‘a bit of a mess’?

Posted by:

In 1968, Martin Goetz was awarded the first patent on his code solution for sorting data. As smartphone wars are inclining and many patent infringements are being filed in the US, Martin thinks that the field is now “a big mess” and hopes that “it will get straightened out in time”.

As patent-frenzy goes out of control, are patent examiners overwhelmed to a point inventions aren’t checked thoroughly? Read more at the Guardian

Continue Reading →
0

Pugatch Consilium at the Life Sciences Invest conference in Russia

Posted by:

Pugatch Consilium is organizing a panel discussion on IPRs at the Life Sciences Invest conference and partnering forum taking place November 29 and 30 in St Petersburg, Russia.

The panel discussion, titled “Intellectual property rights and pharmaceuticals – possibilities and limitations”, will focus on economic functions and benefits of pharmaceutical IPRs and the current IP-related opportunities and challenges in the Russian market. Speakers include local and international experts from from academia, industry and government.

To read more, please see Continue Reading →

0

If it’s not my innovation it’s not worth protecting, although certainly worth using! India declares war on foreign pharmaceutical innovators?

Posted by:

Bayer, Novartis, Roche and Pfizer all stand to lose from the current Indian philosophy towards biomedical innovation generated by foreign firms.

The recent patent revocations of Roche’s hepatitis C drug, Pegasys and Pfizer’s cancer drug, Sutent; the issue of a compulsory license on Bayer’s Nexavar; and the on-going patent dispute with Novartis over its oncology drug, Glivec, are symptoms of a much more fundamental philosophical gap between India (and some other emerging economies) and the west.

It would seem that the antiquated ...

Continue Reading →
0

Growing the paid-for music market in Asia

Posted by:

New initiatives to reduce unauthorized, free access to music that mirror efforts in developed countries are springing up in India and Vietnam.

Saavn, a digital music service for Bollywood and regional Indian music, which offers an ad-supported free service as well as a premium offline service, is much like Spotify. Saavn has licensed more than 1 million tracks and has launched a mobile app aimed at growing users in India as well as in other countries where Indian music is popular, ...

Continue Reading →
0

Professor Meir Pugatch speaking at WIPO/UNECE event

Posted by:

Professor Meir Pugatch will speak at an inter-regional seminar on the economic issues of intellectual property rights organized by a partnership of the World Intellectual Property Organization, the United Nations Economic Commission for Europe and the Israel Patent Office. The event will take place September 11-12, 2012 in Jerusalem. Prof. Pugatch will discuss the economics of IPRs in the 21st century and whether there is need for a paradigm shift in IP policy, with a special focus on the case ...

Continue Reading →
0
Page 5 of 7 «...34567